Drug manufacturer GlaxoSmithKline settles case for $40.8 million
GlaxoSmithKline pays $40.8 million to 37 states over anti-nausea drug Kytril
GlaxoSmithKline LLC and SB Pharmco Puerto Rico Inc. settled a case in Chicago with the attorney general's office for $40.8 million. The drug manufacturer allegedly breached drug manufacturing standards. The Illinois attorney general's office stated that between 2001 and 2004 the companies made bad batches of several medications, including:
- Kytril - anti-nausea drug used by chemotherapy patients,
- Avandamet - a diabetes drug,
- Paxil CR - antidepressant,
- Bactroban - topical antibiotic treatment.
The products in question had previously been recalled or have since expired and the manufacturing facility has closed.
In a settlement agreement in a Chicago courthouse, the Illinois attorney general accused the drug companies of unfair and deceptive practices. GlaxoSmithKline has offices in Philadelphia and Research Triangle Park, North Carolina.
GlaxoSmithKline is the manufacturer of many consumer over-the-counter pharmaceuticals and prescription medications, including:
- Abreva
- Advair
- Aquafresh
- Avandia
- Bactorban
- Boniva
- Commit Lozenge
Drug manufacturer and pharmacy errors can be dangerous and, in some cases, they can have fatal consequences. Pharmaceutical companies invest millions into marketing their drugs and many companies put products on the market before conducting proper product testing. Our firm has represented numerous clients who have suffered because of improper product testing. We have filed claims against virtually every major pharmacy in the country, and David W. Hodges and Galvin B. Kennedy are Board Certified in Personal Injury Trial Law by the Texas Board of Specialization. Fill out our contact form to have an attorney review your case for free.